Deciphera Pharmaceuticals, Inc.Deciphera Pharmaceuticals, Inc.Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

26.040.00 0.00%
The 10 analysts offering 1 year price forecasts for DCPH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to DCPH in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

DCPH EPS for the last quarter is −0.54 USD despite the estimation of −0.58 USD. In the next quarter EPS is expected to reach −0.55 USD. Track more of Deciphera Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Deciphera Pharmaceuticals, Inc. revenue is expected to reach ‪46.20 M‬ USD. Check out Deciphera Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, DCPH price target is 26.04 USD with a max estimate of 30.00 USD and a min estimate of 23.00 USD. Check if this forecast comes true in a year, meanwhile watch Deciphera Pharmaceuticals, Inc. stock price chart and keep track of the current situation with DCPH news and stock market news.
We've gathered opinions of 10 analysts rating DCPH stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.